AOD- 9604
Advanced Obesity Drug Fragment
A Targeted Approach to Metabolic Health and Fat Loss Support
1,000 + Patients Served
24 /7 Telehealth Access
15 + Treatments Available
98 % Patient Satisfaction
Overview
AOD-9604 is a modified peptide fragment derived from the C-terminal portion of human growth hormone (hGH). It is designed to target fat metabolism pathways without significantly affecting blood glucose or systemic growth hormone activity, making it of interest in metabolic and weight management settings.
Potential Clinical Applications
Body composition
improvement strategies
Metabolic optimization in conjunction with lifestyle modification
Targeted fat loss support (particularly resistant adipose areas)
Adjunctive support for weight management programs
Clinical Rationale
AOD-9604 is associated with activity in:
Inhibition of lipogenesis (formation of new fat)
Lipolysis (breakdown of stored fat)
Support of metabolic efficiency and energy utilization
Unlike full growth hormone, this fragment is intended to act selectively on adipose tissue pathways.
Administration
Typically administered via subcutaneous injection, often as part of a structured metabolic or weight management protocol. Treatment plans are individualized.
Wellness & Metabolic Focus
This therapy is positioned within a comprehensive approach to metabolic health—supporting fat metabolism, body composition goals, and overall physiologic balance when combined with nutrition and lifestyle strategies.
This information is provided for educational purposes and reflects a general overview of studied biologic mechanisms. Statements have not been evaluated by the FDA. Individual protocols, appropriateness, and outcomes are determined on a case-by-case basis following clinical evaluation. Individual results may vary.